HCAT - NASDAQ
Health Catalyst, Inc.
$1.33
+1.9%Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
At a Glance
Live Snapshothcat
Selling, General and Administrative Expenses
Last Annual Value
102.04M
3-Year CAGR
-12%
5-Year CAGR
-2%
10-Year CAGR
10%
Health Catalyst, Inc. Competitors Analysis of Selling, General and Administrative Expenses
| Company | Selling, General and Administrative Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Health Catalyst, Inc. NASDAQ:HCAT | 102.04M | -10.8% | -8.7% | N/A | |
 Solana Company NASDAQ:HSDT | 23.13M | 35.6% | 13.7% | N/A | |
 Orchestra BioMed Holdings, Inc. NASDAQ:OBIO | 26.91M | 9.9% | 27.7% | N/A | |
 Cassava Sciences, Inc. NASDAQ:SAVA | 68.80M | 60.8% | 53.6% | 28.1% | |
 Sangamo Therapeutics, Inc. NASDAQ:SGMO | 34.89M | -17.1% | -11.2% | 2.9% | |
 Neuronetics, Inc. NASDAQ:STIM | 97.16M | 10.1% | 8.9% | 13.0% | |
 Enanta Pharmaceuticals, Inc. NASDAQ:ENTA | 43.93M | -6.0% | 6.2% | 10.0% | |
 Pyxis Oncology, Inc. NASDAQ:PYXS | 22.19M | -12.0% | 3.5% | N/A | |
 Aclaris Therapeutics, Inc. NASDAQ:ACRS | 21.97M | -10.9% | -1.4% | 3.8% | |
 Invivyd, Inc. NASDAQ:IVVD | 66.93M | 10.9% | 12.9% | N/A | |
 Atlantic International Corp. NASDAQ:ATLN | 91.29M | 26.2% | 16.7% | 63.0% |
Health Catalyst, Inc. Fair Value Envelope
Related Guides
Continue your HCAT research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.